Table 2.
Target site | Number of mutants | Frequency (%) |
---|---|---|
sgRNA1 | 14 ± 2 | 28.5 ± 4 |
sgRNA2 | 17 ± 1 | 34.6 ± 2 |
sgRNA1 and sgRNA2 | 18 ± 3 | 36.7 ± 6 |
Forty‐nine individual 5‐FOA‐resistant mutants were assessed using the PCR and TA‐cloning sequence assay.